Our Mission
The HPTN develops and evaluates cutting-edge biomedical, behavioral, and structural interventions to reduce the transmission of HIV.
Innovative, transformative, and impactful
23
Active Studies
55
Study Sites
13
Countries
541
Publications
Our Research Agenda
The HPTN research agenda focuses on four strategies:
- Long-acting antiretroviral (ARV) agents for pre-exposure prophylaxis (PrEP)
- Multipurpose prevention technologies (MPTs)
- Broadly neutralizing antibodies (bnAbs)
- Integrated strategies for HIV prevention
Happening at HPTN
Important Changes to the 2025 HPTN Annual Meeting
The 2025 HPTN Annual Meeting will take place virtually June 2 to 4. This year, we are implementing a new registration process to ensure all invited participants have the appropriate access to meeting content, discussions, and outcomes. Please review these changes before applying to register.
Read more
Fostering the next era of researchers
HPTN Scholars Program
The HPTN Scholars Program seeks to provide scholar recipients with the knowledge, skills, and connections to further their careers as independent investigators in the HIV prevention research field.
Learn More